Minneapolis Clinical Trials
Cure Study
Purpose: to evaluate the safety and tolerability of a potential new drug for cystic fibrosis.
13 nights
1 visits
Participate in a clinical study of a potential treatment for cystic fibrosis. This is the multiple dosing portion of the study (MAD).
This study has 1 screening appointment and 13 nights/ 14 days inpatient stay and 1 follow up phone call.
Reimbursement for study participation will be provided for time and travel of up to $7,170.
This study has been reviewed by an Institutional Review Board.
Call 612-315-6490 to discuss your eligibility today!
Eligibility
Age: 18-55
BMI: 18-32kg/m2
Medications: No current OTV or prescribed medications (other than birth control)
Smoking Status: Non-smoker or must be able to stop smoking during the study
Contraception: Must be willing to follow contraception guidelines from at least 14 days prior to the first dose through 60 days after the last dose.
Compensation: Up to $7,170